Translational Development Acquisition Corp. (TDAC)
NASDAQ: TDAC · Real-Time Price · USD
10.32
0.00 (-0.02%)
Aug 15, 2025, 4:00 PM - Market closed
Company Description
Translational Development Acquisition Corp. does not have significant operations.
It intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses.
Translational Development Acquisition Corp. was incorporated in 2022 and is based in New York, New York.
Translational Development Acquisition Corp.
| Country | United States |
| Founded | 2022 |
| IPO Date | Dec 23, 2024 |
| Industry | Shell Companies |
| Sector | Financials |
| CEO | Michael M. Hoffman |
Contact Details
Address: 52 E. 83rd Street New York, New York 10028 United States | |
| Phone | 917 979 3072 |
| Website | translational-development.com |
Stock Details
| Ticker Symbol | TDAC |
| Exchange | NASDAQ |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| IPO Price | $10.00 |
| CIK Code | 0001926599 |
| CUSIP Number | G9008W105 |
| ISIN Number | KYG9008W1050 |
| SIC Code | 6770 |
Key Executives
| Name | Position |
|---|---|
| Michael M. B. Hoffman J.D. | Chairman of the Board and Chief Executive Officer |
| Avi C. Das | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Aug 14, 2025 | 8-K | Current Report |
| Aug 14, 2025 | 10-Q | Quarterly Report |
| Jul 31, 2025 | SCHEDULE 13G/A | Filing |
| Jul 11, 2025 | SCHEDULE 13G/A | Filing |
| May 15, 2025 | 10-Q | Quarterly Report |
| May 14, 2025 | SCHEDULE 13G/A | Filing |
| May 14, 2025 | SCHEDULE 13G/A | Filing |
| May 8, 2025 | SCHEDULE 13G | Filing |
| May 1, 2025 | SCHEDULE 13G | Filing |
| Mar 31, 2025 | 10-K | Annual Report |